Key Takeaways
- A new study shows medical students are eager to learn about doctors medical cannabis but lack formal education.
- 80.4% of students support adding cannabis content to medical school curricula, yet they score poorly on related knowledge tests.
- Many students feel unprepared to discuss medical cannabis with patients due to gaps in education and curriculum.
- Those with personal experience using cannabis scored higher on knowledge tests, highlighting the reliance on informal education.
- The federal rescheduling of cannabis could lead to improved training and confidence among future physicians in discussing cannabis with patients.
For decades, the doctor’s office was not exactly a welcoming place to bring up marijuana. Ask your physician about medical cannabis for chronic pain or anxiety, and you were likely met with a shrug, a warning, or silence born from a knowledge gap nobody wanted to admit existed. That dynamic is shifting, and a new study out of Wayne State University School of Medicine shows exactly why.
The research, published in this months version of the Journal of Cannabis Research surveyed 250 incoming medical students and found a group eager to learn about medical cannabis, even though their formal education has left them without the tools to do it. It is a snapshot of a profession in transition, caught between an older generation trained to see cannabis as taboo and a younger one that grew up watching legalization spread state by state.
A New Study Reveals What Medical Students Really Think About Cannabis
Researchers at Wayne State surveyed incoming students during orientation, before any of them had taken a single class. Of the 304 students invited, 82% responded, giving the study a solid sample size for a single-institution project.
The numbers paint a picture, 80.4% of students supported adding medical cannabis content to medical school curricula, and 73.6% wanted it included in residency training too. That is not a passing interest. 76% of respondents agreed that cannabis helps patients with chronic, debilitating conditions, and 58.4% supported changing marijuana’s federal scheduling status entirely.
These are students who have not yet been shaped by years of institutional caution. They arrived at medical school already believing cannabis has a legitimate place in patient care. The researchers noted this is an important shift, especially considering that fewer than 10% of medical school curricula currently include any cannabis-related content at all.
What makes this study different from earlier research is its scope. Rather than just asking students how they feel about cannabis, the researchers tested actual knowledge across three areas: medical indications, adverse effects, and the differences between THC and CBD. The results exposed a real problem hiding behind all that enthusiasm.
Why Do So Many Future Doctors Feel Unprepared to Discuss Medical Marijuana?
Here is where the study gets uncomfortable. Despite their favorable attitudes, students performed poorly on every knowledge test. They answered just 53.7% of questions about medical indications correctly, 46.1% on adverse effects, and only 45.4% on the differences between THC and CBD.
Even more telling, 61.2% of students said they did not feel prepared to answer a patient’s questions about cannabis, and 67.2% said they felt unprepared to actually counsel someone on its use. That is roughly two out of every three future doctors admitting they would not know what to say if a patient brought up medical marijuana during an appointment.
This is not a new problem, either. Earlier research cited in the study found that 66.7% of medical school curriculum deans believed their graduates were not adequately educated on medical cannabis to make patient recommendations, and only 6% felt their graduates would be prepared to suggest it. Physicians already in residency have reported similarly low confidence, with just 23.3% feeling even moderately prepared to field patient questions.
Students seemed aware of some gaps but not others. They rated their understanding of THC versus CBD fairly high, at an average of 3.68 out of 5, even though that was the exact area where they performed worst. In other words, confidence and competence did not line up, a pattern that should give any future patient pause.
How Does Personal Experience With Cannabis Shape Physician Knowledge?
One of the more interesting findings involves where students actually pick up their cannabis knowledge. About 34.4% of respondents said they personally knew someone who had used medical cannabis, and this group scored significantly higher on questions about medical indications and THC versus CBD differences, even after researchers controlled for age, gender, and prior healthcare experience.
That means a meaningful chunk of what future doctors know about cannabis is coming from personal relationships rather than classrooms. It is a workaround born of necessity, but it is not exactly the kind of standardized, evidence-based education you want shaping how physicians treat patients.
Researchers wrote that incoming medical students “hold largely favorable attitudes toward MC that are incongruent with their knowledge deficits,” and pointed out that informal personal exposure, rather than formal education, is shaping what future doctors actually understand about the plant. That is a glaring admission from a peer-reviewed medical journal, and it highlights just how far behind the curriculum has fallen compared to real-world attitudes.
What Changed When the Federal Government Rescheduled Medical Marijuana?
Context matters here, and 2026 has delivered plenty of it. On April 22, 2026, the DEA finalized an order moving FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule III, following a December 2025 executive order from President Trump directing the Department of Justice to complete the process.
Acting Attorney General Todd Blanche framed the move in terms that echo exactly what the Wayne State researchers found among students. “This rescheduling action allows for research on the safety and efficacy of this substance,” he said, “ultimately providing patients with better care and doctors with more reliable information.”
For the first time, the federal government has formally acknowledged that marijuana has an accepted medical use, a recognition that comes as 40 states have adopted medical marijuana programs and 24 states plus Washington, D.C. have legalized recreational use. This is not a fringe issue anymore. It is a mainstream part of American healthcare that the classroom has simply not caught up to.
Is This Really a Changing of the Guard in Medicine?
It is hard not to see generational lines here. Physicians trained during the height of the war on drugs came up in a system that treated cannabis as strictly illicit, with no perceived medical upside and plenty of institutional discouragement around even discussing it seriously. Many of those doctors are still practicing, and their comfort level with cannabis reflects that era.
The students entering medical school now grew up watching states legalize marijuana one after another. They have seen dispensaries open in their hometowns, watched family members use cannabis for chronic pain or anxiety, and came of age as public opinion shifted dramatically in favor of legalization. Their baseline assumption is not “is this dangerous,” but rather “how does this work and how do I use it responsibly with patients.”
That shift in mindset is exactly what the Wayne State study captured. Younger physicians in training are not carrying the same stigma their predecessors did. What they lack is not willingness, it is structured education.
As legal cannabis becomes further embedded in mainstream medicine through rescheduling and expanding state programs, this generational gap in comfort versus competence will only become more visible in exam rooms across the country.
What Comes Next for Cannabis Education in Medicine?
The researchers behind this study were clear about their conclusion. They called for “standardized, evidence-based MC education across medical training,” arguing that current gaps leave future physicians unable to offer the safe, informed guidance patients deserve as cannabis use continues to grow.
Medical schools now have data showing overwhelming student demand for this kind of curriculum. The question is whether institutions will act on it before another generation of doctors graduates without the tools to answer a simple question their patients are already asking. Given how quickly cannabis policy is moving at the federal level, waiting is starting to look like the riskier option.
Frequently Asked Questions
A recent study found that most incoming medical students support adding medical cannabis to their curriculum and believe it benefits patients with chronic conditions. Yet their knowledge of cannabis remains low, revealing a significant gap between their attitudes and their preparedness.
A Wayne State University study found that less than 10% of medical schools teach cannabis-related content, leaving most medical students unprepared to answer patient questions about medical cannabis.
In April 2026, marijuana was moved to Schedule III — the first time the federal government officially recognized its medical use. Backed by Acting Attorney General Todd Blanche, the change is expected to expand cannabis research and give doctors better information to guide patient care.
Younger medical students tend to have more positive views on medical cannabis than older physicians, though both groups lack formal education on the topic.
According to the study, fewer than 10% of medical school curricula include content on medical cannabis, despite growing patient use and expanding state medical marijuana programs across 40 states.
